In Mao and coworkers237 study, combinational targeting of DNA‐PKcs and PARP1 suppressed hepatocellular carcinoma (HCC) growth in both mice model and HCC patient‐derived‐xenograft model. The gene discussed is PARP1; the disease is hepatocellular carcinoma.